Telavant produces drugs for people suffering from inflammatory and fibrotic diseases and is in the process of developing a 'promising new therapy' for patients with Crohn's disease.
Sanofi's Lantus, its most commonly prescribed insulin, will sell for $35 a month through GoodRx Holdings Inc. in a deal that signals the drug-discount site's growing business with large pharma companies.
The drugs appear to have a protective effect on the heart, liver and kidneys in addition to helping people lose weight, which in itself reduces the risk of many ailments.
Debt-laden Rite Aid filed for bankruptcy protection on Sunday and said it would close underperforming stores, as the drugstore chain comes under pressure from lawsuits alleging that it helped fuel the opioid crisis.